# FDA Inspection 852553 - Biomat USA, Inc - October 24, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d69e210b-5ec8-4911-8dc8-4fea1d548bca
Source feed: FDA_Inspections

> FDA Inspection 852553 for Biomat USA, Inc on October 24, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 852553
- Company Name: Biomat USA, Inc
- Inspection Date: 2013-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1106436 - 2019-10-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/58a3a518-95fd-4523-9993-f14336448eb9)
- [FDA Inspection 1026015 - 2017-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/59e3725e-44d2-4664-88c3-2153b6c65869)
- [FDA Inspection 922269 - 2015-04-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/91b36fd4-187e-4de1-b23b-dfa099df917e)
- [FDA Inspection 737675 - 2011-07-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/498bd0f3-0d18-42dc-9687-8d340ce147f5)
- [FDA Inspection 669134 - 2010-06-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9cc8ea14-f75a-43ea-ac39-1271a3e950cc)

Company: https://www.keypedia.com/companies/biomat-usa-inc/1e28a624-a527-4a88-96c4-0062724b8eaf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d